474407-10-8Relevant academic research and scientific papers
Fabrication of a Kagomé-type MOF Membrane by Seeded Growth on Amino-functionalized Porous Al2O3 Substrate
Wang, Xiaoguang,Kusaka, Shinpei,Hori, Akihiro,Matsuda, Ryotaro
supporting information, p. 2018 - 2021 (2021/06/25)
In this study, we report an efficient fabrication method for the membrane of a metal-organic framework (MOF) (Kgm?OEt) which is one kind of kagomé-type MOF with a two-dimensional (2D) sheet structure having one-dimensional (1D) channels suitable for separ
Two-Dimensional versus Three-Dimensional Self-Assembly of a Series of 5-Alkoxyisophthalic Acids
Frederick, Esther,Cojal González, José D.,Rabe, Jürgen P.,Bernasek, Steven L.
, p. 10739 - 10747 (2018/09/06)
Physisorbed self-assembled monolayers (SAMs) have been suggested as potential models for three-dimensional (3D) crystallization. This work studies the effect of altering the chain length of 5-alkoxyisophthalic acid (CnISA) on self-assembled mor
Self-Exfoliated Metal-Organic Nanosheets through Hydrolytic Unfolding of Metal-Organic Polyhedra
Garai, Bikash,Mallick, Arijit,Das, Anuja,Mukherjee, Rabibrata,Banerjee, Rahul
supporting information, p. 7361 - 7366 (2017/05/31)
Few-layers thick metal-organic nanosheets have been synthesized using water-assisted solid-state transformation through a combined top-down and bottom-up approach. The metal-organic polyhedra (MOPs) convert into metal-organic frameworks (MOFs) which subse
MACROCYCLIC LACTAMS AND PHARMACEUTICAL USE THEREOF
-
Page/Page column 74, (2008/06/13)
The present invention relates to novel macrocyclic compounds of the formula (I) wherein R1, R2, R3, U, V, W, X, Y, Z and n are as defined in the specification, the number of ring atoms included in the macrocyclic ring being 14, 15, 16 or 17, in free base form or in acid addition salt form, to their preparation, to their use as pharmaceuticals and to pharma-ceutical compositions comprising them.
HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
Page 28-29, (2010/02/07)
The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated-amyloid levels or-amyloid deposits, particularly Alzheimer's disease.
Highly luminescent, triple- and quadruple-stranded, dinuclear Eu, Nd, and Sm(III) lanthanide complexes based on bis-diketonate ligands
Bassett, Andrew P.,Magennis, Steven W.,Glover, Peter B.,Lewis, David J.,Spencer, Neil,Parsons, Simon,Williams, Rene M.,De Cola, Luisa,Pikramenou, Zoe
, p. 9413 - 9424 (2007/10/03)
The bis(β-diketone) ligands 1,3-bis(3-phenyl-3-oxopropanoyl)benzene, H2L1 and 1,3-bis(3-phenyl-3-oxopropanoyl) 5-ethoxy-benzene, H2L2, have been prepared for the examination of dinuclear lanthanide complex forma
